Found: 6
Select item for more details and to access through your institution.
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1116937
- By:
- Publication type:
- Article
Injectable Shear‐Thinning Hydrogels with Sclerosing and Matrix Metalloproteinase Modulatory Properties for the Treatment of Vascular Malformations.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 51, p. 1, doi. 10.1002/adfm.202305880
- By:
- Publication type:
- Article
Egg White Photocrosslinkable Hydrogels as Versatile Bioinks for Advanced Tissue Engineering Applications.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 32, p. 1, doi. 10.1002/adfm.202315040
- By:
- Publication type:
- Article
Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications.
- Published in:
- Journal of Tissue Engineering & Regenerative Medicine, 2014, v. 8, n. 1, p. 1, doi. 10.1002/term.1494
- By:
- Publication type:
- Article
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. 809, doi. 10.1093/oncolo/oyac155
- By:
- Publication type:
- Article
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. 809, doi. 10.1093/oncolo/oyac155
- By:
- Publication type:
- Article